Is the performance of high sensitivity troponin for the diagnosis of acute myocardial infarction underestimated?
hsTnT has superior sensitivity for myocardial infarction than even assays at or near guideline precision requirements (Abbott and Vitros TnI). The specificity of hsTnT assay is not as poor as previous analyses suggest.
mTOR pathway inhibition may represent a viable therapy for NF1 bone diseases.